The only treatment for Alpha-1 lung disease is plasma-derived therapy, which makes plasma donation essential for the Alpha-1 community. This International Plasma Awareness Week (#IPAW2025), join A1F and Alpha-1 Europe Alliance asbl to raise awareness and inspire action!

🌍 During #IPAW2025, join us in raising awareness of the vital role plasma donors play in global health. Watch our short documentary: youtube.com/watch?v=j2nbBd…

Plasma is more than water. It contains vital proteins such as alpha-1 antitrypsin that are critical for patient treatments. In honor of #IPAW2025, A1F and Alpha-1 Europe Alliance asbl invite you to educate members of your local community about the power of plasma and the importance of

If you'll be at the PPTA #PPTAForum, don’t miss Panel I: Building Resilience Together: Industry Collaboration on Emergency Preparedness with Haemonetics' CMO Dr. Jan Hartmann. 📅 Oct 16 | 10:25–11:00 a.m. 🔗 pptaglobal.org/events/ppta-bu…

Behind every plasma donation is a patient or family whose life has been changed by plasma-derived medicines. International Plasma Awareness Week highlights the voices of patients, caregivers, and medical professionals whose experiences illustrate the impact of plasma donations,

During #IPAW2025, the numbers tell an important story. In a new survey, PPTA found that 72% of Americans agree that plasma-derived medicines can save lives. Yet 8 in 10 have never donated. Nearly half who haven’t donated say they just don’t know enough about it. That’s why

Plasma-derived therapies such as IVIG and SCIG are life-changing and life-sustaining for my patients with immune deficiencies." - Katie Smiley, PA-C, Allergy & Asthma Medical Group and Research Center of San Diego, CA. Become a plasma advocate today! Visit

#ThankYouPlasmaDonors! For many patients, plasma is a life-changing gift. The generosity of healthy, committed plasma donors can help many individuals and families lead normal, healthy lives. As #IPAW2025 comes to a close, remember that #PlasmaPowersPossibility year-round! Learn

Miss the #IPAW2025 patient webinar? The full conversation is now available on YouTube! Hear directly from patients and infusion nurse as they share real-world experiences with plasma-derived medicines in a discussion moderated by PPTA President and CEO Anita Brikman. ▶️ Watch

An inspiring keynote from Dr. Namandje Bumpus set the stage for discussions on ensuring regulatory excellence during times of turbulence and change. She challenged the audience by asking "How do we increase collaboration in meaningful and purposeful ways despite change?"

Then, the first session of the day brought timely insights into U.S. trade policy and its implications for plasma and PDTs with Julia Fabens reminding attendees that "This is a global industry that serves patients around the world while maintaining a robust U.S. presence." The

These discussions highlighted how global and national forces shape our ability to ensure safe, reliable plasma-derived medicines for patients worldwide. Keep following along as there are still several impactful sessions to follow at this year's #PlasmaProteinForum!

Good morning from Day 2 of the #PlasmaProteinForum! Today promises another round of engaging discussions! Thank you to our speakers, sponsors, and attendees for your continued contributions. Let’s make Day 2 of #PPF2025 as impactful as Day 1!

The final day of the #PlasmaProteinForum began with an informative keynote from Dr. Mario Macis of Johns Hopkins Carey Business School who provided research-driven perspectives on incentive-based behaviors and patterns. The next panel examined the lifesaving role of anti-D plasma with insights from

Approved plasma medicines are packaged and distributed globally through regulated supply chains, with cold storage often required to maintain efficacy. Collaborative efforts between logistics providers and health care systems help overcome geographic and infrastructure barriers

Approved medicines are packaged and distributed globally through regulated supply chains, and cold storage is often required to maintain their efficacy. Collaborative efforts between logistics providers and health care systems help overcome geographic and infrastructure

PPTA collaborates with regulators like the FDA and EMA to keep patients and science at the heart of policy decisions. Hear from James Knowles, Ph.D., PPTA’s Senior Director of Global Regulatory Policy, on how PPTA uses data and expertise to help shape patient-centered